Thyroid Eye Disease Treatment Options: When Lubrication, PROKERA, or TEPEZZA May Help

Thyroid eye disease does not affect everyone the same way. For some people, it begins with dryness, redness, puffiness, and irritation that feel more annoying than alarming. For others, it becomes much more disruptive, with bulging eyes, pressure, double vision, or changes in vision itself. That is why treatment for thyroid eye disease is never one-size-fits-all. The right plan depends on what part of the disease is causing the most trouble: the surface of the eye, the tissues behind the eye, or both.

A quick refresher: thyroid eye disease (TED) is an autoimmune condition that affects the muscles, fat, and connective tissue around the eyes. It is most commonly linked to Graves’ disease, but it can also occur in people with normal thyroid levels or low thyroid levels. Common symptoms include dry eyes, red eyes, swelling, bulging, pressure, and double vision. When the disease is mild, treatment may focus on comfort and protecting the eye surface. When it is more active or more severe, treatment may need to target the disease process itself.

Below is a guide to how treatment options are often approached.

1. Lubrication may help when the main problem is dryness and exposure

For many patients, the first part of treatment is not a high-tech medication. It is protection. Thyroid eye disease often makes the surface of the eye more exposed because the eyelids may not close normally or the eyes may sit more forward than usual. That exposure can lead to burning, grittiness, watering, redness, fluctuating blur, and light sensitivity. When that is the main issue, lubrication becomes a core part of treatment, not an afterthought.

This usually means preservative-free artificial tears during the day and a thicker lubricating ointment at night. Some patients also benefit from cool compresses, moisture protection while sleeping, or other measures to reduce exposure-related irritation. These treatments may sound simple, but they can make a meaningful difference when the eye surface is dry, inflamed, and poorly protected.

Why this helps: Lubrication does not treat every part of thyroid eye disease, but it can reduce friction, improve comfort, and protect the cornea while the rest of the condition is being evaluated and managed.

Why it may not be enough: If the disease is more active, or if the cornea is already becoming damaged from exposure, drops alone may not fully solve the problem. That is when the treatment conversation often needs to expand.

2. Surface healing becomes more important when dryness turns into damage

Not all “dry eye” in thyroid eye disease is the same. Some patients have irritation but no real injury to the surface of the eye. Others develop more serious exposure-related problems, where the cornea becomes inflamed, unstable, or damaged because it is not being protected well enough. This is the point where treatment shifts from simple comfort to surface healing.

Patients often notice this stage when their symptoms no longer feel mild or occasional. The eyes may feel painfully dry, unusually sensitive to light, hard to keep open, or much blurrier than expected. The surface may stay red and irritated despite repeated use of tears. When that happens, it is important not to assume you simply need “stronger drops.” Sometimes the cornea needs more active support.

Why this matters: The front surface of the eye needs to stay smooth and healthy for clear, comfortable vision. If thyroid eye disease is causing too much exposure, protecting that surface becomes a major part of preserving vision and comfort.

3. PROKERA may be considered when the eye surface needs more than drops

PROKERA is not a general dry-eye drop and it is not the same type of treatment as TEPEZZA. PROKERA is a cryopreserved amniotic membrane device designed to support corneal healing, reduce inflammation, and reduce scarring on the eye’s surface. BioTissue describes it as a biologic corneal bandage that helps damaged eye surfaces heal.

In thyroid eye disease, PROKERA may come into the picture when the main issue is severe surface irritation, exposure-related corneal damage, or poor healing of the eye surface. In other words, it is not usually the first treatment for mild dryness, and it is not the primary disease-modifying treatment for TED itself. It is better understood as a treatment that may help when thyroid eye disease has caused the surface of the eye to become significantly inflamed or injured.

Some patients have never heard of PROKERA until they reach the point where standard lubrication is no longer doing enough. That is one reason it can feel like an “advanced” treatment, even though the main goal is straightforward: help the eye surface heal better than it is healing on its own. For the right patient, that can be an important part of reducing pain, improving surface health, and protecting the cornea.

Why it helps: It supports healing of the damaged surface.

Why it is not the whole story: If thyroid eye disease is also causing significant bulging, pressure, double vision, or active inflammation behind the eye, surface treatment alone may not be enough.

4. TEPEZZA may be discussed when the disease itself needs treatment

When thyroid eye disease is doing more than causing surface dryness, treatment may need to go beyond supportive care. That is where TEPEZZA may enter the conversation. TEPEZZA is the brand name for teprotumumab-trbw, and the current FDA prescribing information states that it is indicated for the treatment of thyroid eye disease regardless of activity or duration.

This is an important distinction. Lubrication and surface therapies help manage symptoms and protect the front of the eye. TEPEZZA is used when the goal is to treat the broader thyroid eye disease process, particularly in patients whose symptoms are more clinically significant. AAO has described it as the first nonsurgical treatment approved for TED, and more recent AAO guidance notes that treatment choice depends on disease severity and patient-specific factors.

According to the FDA label, TEPEZZA is given as 8 intravenous infusions, one every 3 weeks. The label also highlights important safety considerations, including infusion reactions, hyperglycemia, hearing impairment, and inflammatory bowel disease precautions. That does not mean it is the wrong treatment. It means candidacy needs thoughtful review, and the decision should be individualized.

Why it may help: TEPEZZA is aimed at the disease process itself, not just the eye surface symptoms.

Why it requires careful selection: It is a medical treatment with real benefits and real considerations, so patients need a proper evaluation before deciding whether it fits their situation.

5. Not every patient needs the same level of treatment

One of the most helpful things for patients to understand is that thyroid eye disease exists on a spectrum. Some people mainly need lubrication, surface protection, and observation. Some need stronger ocular-surface treatment because the cornea is becoming compromised. Others need discussion of medical therapy because the disease is affecting appearance, comfort, eye movement, or vision more significantly. The ATA/ETA consensus statement emphasizes that treatment should be tailored to disease severity and the structures involved.

That is why comparing your symptoms to someone else’s experience can be misleading. One patient may have mostly dryness and redness. Another may have obvious bulging and double vision. Another may have both severe surface disease and deeper orbital inflammation at the same time. The “best treatment” depends on which of those problems is actually present.

6. The right treatment plan often includes more than one layer

In real life, thyroid eye disease treatment is often not either-or. A patient may need lubrication for comfort, PROKERA for surface healing, and evaluation for TEPEZZA if the disease itself is more active or more disruptive. These are not interchangeable treatments. They address different parts of the problem.

This is where specialist evaluation becomes especially valuable. A patient may come in thinking the issue is only dryness, only to learn that the lid position and eye prominence are creating more exposure than expected. Another patient may be focused on appearance changes, only to realize the cornea is already taking a toll. A careful exam helps sort out which part of the disease needs the most attention first.

Why early treatment discussions matter

Patients do not need to wait until symptoms are extreme to ask about treatment. In fact, that is often the wrong moment to start the conversation. Earlier recognition can help protect the ocular surface, identify patients whose disease is becoming more active, and create a treatment plan before the condition becomes more disruptive to daily life. The ATA/ETA consensus statement specifically notes that TED can cause substantial quality-of-life burden and that treatment options have expanded in recent years.

It also helps patients avoid a common cycle: trying drop after drop for months, feeling that nothing is really fixing the problem, and not realizing there are other ways to think about treatment. Sometimes the issue really is mild and supportive care is enough. Sometimes it is not. The only way to know which situation you are in is to have the disease evaluated as TED, not just as “dry eye.”

What to do if you think you need more than eye drops

If your eyes are:

• dry and irritated all the time

• red or swollen more than usual

• painful from exposure or light

• looking more prominent

• developing double vision

• not improving with ordinary dry-eye treatment

it may be time to ask whether your treatment plan should go beyond lubrication alone.

Action steps

• schedule an evaluation with an eye specialist familiar with thyroid eye disease

• mention any history of Graves’ disease, hyperthyroidism, hypothyroidism, or thyroid autoimmune disease

• bring a list of what treatments you have already tried

• do not ignore worsening pain, double vision, or changes in vision

  
  

What this means for your eyes

Thyroid eye disease treatment is not about choosing the “most advanced” option first. It is about choosing the right level of treatment for the problem you actually have. For some patients, that means lubrication and surface protection. For others, it means advanced surface healing with PROKERA. For others, it means discussing whether TEPEZZA is appropriate. And for some, it may mean a combination of these approaches.

The encouraging part is that treatment options do exist. You do not have to stay stuck in the cycle of assuming everything is “just dry eye” when the symptoms say otherwise. The sooner the pattern is recognized, the easier it becomes to build a treatment plan that actually matches the disease.

Book with us

If you have thyroid eye disease symptoms and want to understand whether lubrication, PROKERA, TEPEZZA, or another treatment approach may fit your case, book an evaluation with our team.

Request Appointment